Middle East African Journal of Ophthalmology

Aims & Scope

The Middle East African Journal of Ophthalmology (MEAJO), published four times per year in print and online, is an official journal of the Middle East African Council of Ophthalmology (MEACO).

It is an international, peer-reviewed journal whose mission includes publication of original research of interest to ophthalmologists in the Middle East and Africa, and to provide readers with high quality educational review articles from world-renown experts.

MEAJO, previously known as Middle East Journal of Ophthalmology (MEJO) was founded by Dr Akef El Maghraby in 1993.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	0.3
2024	0.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.258

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	39

Journal Rank

Year	Value
2024	18279

Journal Citation Indicator

Year	Value
2024	99

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Diabetic retinopathy and inflammation: Novel therapeutic targets

  Citation: 174

  Authors: Arup, Sampathkumar, PaulG

• Uveal metastasis: Clinical features and survival outcome of 2214 tumors in 1111 patients based on primary tumor origin

  Citation: 107

  Authors: CarolL, RJoel, Kunal, LuisA, EvanB, JenniferH, EileenL, AlexandruB, MeredithA, MarkP, AustenN, AlexanderE, AlexJ, SeanP, JerryA

• Epidemiology of glaucoma in Sub-Saharan Africa: Prevalence, incidence and risk factors

  Citation: 105

  Authors: Fatima, MohammedM, Andrew, ClareE, Hannah

• Continuing professional development: Best practices

  Citation: 104

  Authors: HelenaP, EduardoD, AndriesA, KarlC

• Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population

  Citation: 104

  Authors: AbdulazizA, AbdulwahabS, AbdulrahmanA, AbdullahA, MohammedB, AbdulrahmanM, AmmarM, MohammedA, AhmadH, IsmailZ, AbdullahA

• Adult learning principles and presentation pearls

  Citation: 98

  Authors: AnaG, PeterA

• Role of inflammation in the pathogenesis of diabetic retinopathy

  Citation: 98

  Authors: AhmedM

• Nanotechnology approaches for ocular drug delivery

  Citation: 94

  Authors: RangaramanujamM, Qingguo, SivaP

• Idiopathic orbital inflammation: Review of literature and new advances

  Citation: 93

  Authors: AhmetKaan, YaÄŸmurSeda

• Imaging in diabetic retinopathy

  Citation: 91

  Authors: AndreJ, DavidA

---